Drug Patents owned by Noven

1. Drug name - MINIVELLE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9724310 NOVEN Transdermal estrogen device and delivery
Jul, 2028

(5 years from now)

US8231906 NOVEN Transdermal estrogen device and delivery
Jul, 2030

(7 years from now)

EP2310001A2 NOVEN Transdermal Estradiol Device And Delivery
Feb, 2017

(5 years ago)

EP2310001B1 NOVEN Transdermal Estradiol Device And Delivery
Feb, 2017

(5 years ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9730900 NOVEN Transdermal estrogen device and delivery Jul, 2028

(5 years from now)

US9833419 NOVEN Transdermal estrogen device and delivery Jul, 2028

(5 years from now)

Drugs and Companies using ESTRADIOL ingredient

Treatment: A method for administering estradiol comprising a monolithic transdermal drug delivery system consisting of (i) a backing layer and (ii) a single adhesive polymer matrix layer as claimed in us patent no. 9730900

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
0.025MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription
0.0375MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription
0.05MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription
0.075MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription
0.1MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.